Greenwich, CT, United States of America

Julius A Vida


Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 56(Granted Patents)


Location History:

  • Billerica, MA (US) (1976)
  • DeWitt, NY (US) (1977)
  • New York, NY (US) (1977 - 1981)
  • Greenwich, CT (US) (1977 - 1982)

Company Filing History:


Years Active: 1976-1982

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Julius A. Vida in Therapeutic Compositions

Introduction: Julius A. Vida, an accomplished inventor based in Greenwich, CT, has made significant strides in the field of medicinal chemistry. With a total of 14 patents to his name, Vida’s work primarily focuses on therapeutic compositions that have advanced the treatment of convulsions through the development of various derivatives of barbituric acid and diphenylhydantoin.

Latest Patents: Among Vida’s latest innovations are the patents involving Alkoxymethyl and Benzyloxymethyl phenobarbital therapeutic compositions. These patents detail compounds where alkoxymethyl or benzyloxymethyl groups are intricately attached to the nitrogen atoms of the rings. The described therapeutic compositions highlight their use as effective anti-convulsant agents, showcasing his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights: Throughout his career, Vida has collaborated with prominent companies like Bristol-Myers Company and The Kendall Company. His extensive experience in the industry has equipped him with the knowledge and insight necessary for pioneering advancements in therapeutic innovations.

Collaborations: Vida has worked closely with notable coworkers, including Carlos M. Samour and Kenneth A. Kerridge. Their collective expertise and dedication have supported the innovative processes that have facilitated the development of Vida's patented therapeutic compositions.

Conclusion: Julius A. Vida’s contributions to the field of medicinal chemistry are both remarkable and impactful. Through his 14 patents, he has demonstrated a commitment to enhancing therapeutic options for convulsions, making strides in the pharmaceutical landscape. His collaborative endeavors and career achievements exemplify the spirit of innovation that drives progress in the world of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…